The transplant vasculopathy as a sign of chronic graft rejection affects both the epicardial and the intramyocardial arteries of the graft. This is at least partially mediated by NO synthases. The aim of this study was to assess possible protective effects of cyclosporine A (CsA), tacrolimus (FK506), and mycophenolate mofetil (MMF) on the expression of NO synthases in an experimental transplant rat model.

Aims

Heart transplantation was performed in 322 rats. These were randomly assigned to four equal groups (control, CsA, FK506, MMF). Recipients were monitored up to 60 days after transplantation, while transplanted hearts were recovered at certain time points for analysis. Expression and staining intensity for endothelial nitric oxide synthases (e-nos) and inducible nitric oxide synthases (i-nos) were analyzed in epicardial and intramyocardial vessels in each group.

Results

All employed drugs led to a significant reduction of expression or staining intensity of i-nos and e-nos. MMF was most effective in reduction in expression of both NO synthases.

Conclusions

These results imply that all described drugs prevent endothelial impairment induced by toxicity of NO and thereby prevent transplant vasculopathy. MMF seems to be the most effective drug.

References

1Hayry P. Pathophysiology of chronic rejection. Transplant Proc 1996; 28(6 Suppl 1): 7–10.
PubMed Web of Science® Google Scholar
2Hayry P, Myllarniemi M, Calderon Ramirez L, et al. Immunobiology and pathology of chronic rejection. Transplant Proc 1997; 2: 77–78.
10.1016/S0041-1345(96)00014-0
Web of Science® Google Scholar
3Wildhirt SM, Weis M, Schulze C, et al. Coronary flow reserve and nitric oxide synthases after cardiac transplantation in humans. Eur J Cardiothorac Surg 2001; 19: 840–847.
10.1016/S1010-7940(01)00681-9
CAS PubMed Web of Science® Google Scholar
4Cai B, Roy DK, Sciacca R, Michler RE, Cannon PJ. Effects of immunosuppressive therapy on expression of inducible nitric oxide synthase (iNOS) during cardiac allograft rejection. Int J Cardiol 1995; 50: 243–251.
10.1016/0167-5273(95)02384-9
CAS PubMed Web of Science® Google Scholar
5Weis M, Wildhirt SM, Schulze C, et al. Coronary vasomotor dysfunction in the cardiac allograft: Impact of different immunosuppressive regimens. J Cardiovasc Pharmacol 2000; 36: 776–784.
10.1097/00005344-200012000-00014
CAS PubMed Web of Science® Google Scholar
6Li D, Tomson K, Yang B, Mehta P, Croker BP, Mehta JL. Modulation of constitutive nitric oxide synthase, bcl-2 and Fas expression in cultured human coronary endothelial cells exposed to anoxia-reoxygenation and angiotensin II: Role of AT1 receptor activation. Cardiovasc Res 1999; 41: 109–115.
10.1016/S0008-6363(98)00196-5
CAS PubMed Web of Science® Google Scholar
7Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78: 915–918.
10.1016/0092-8674(94)90266-6
CAS PubMed Web of Science® Google Scholar
8Senda M, DeLustro B, Eugui E, Natsumeda Y. Mycophenolic acid, an inhibitor of IMP dehydrogenase that is also an immunosuppressive agent, suppresses the cytokine-induced nitric oxide production in mouse and rat vascular endothelial cells. Transplantation 1995; 60: 1143–1148.
10.1097/00007890-199511270-00015
CAS PubMed Web of Science® Google Scholar
9Shears LL, Kawaharada N, Tzeng E, et al. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J Clin Invest 1997; 100: 2035–2042.
10.1172/JCI119736
CAS PubMed Web of Science® Google Scholar
10Akita K, Dusting GJ, Hickey H. Suppression of nitric oxide production by cyclosporin A and FK506A in rat vascular smooth muscle cells. Clin Exp Pharmacol Physiol 1994; 21: 231–233.
10.1111/j.1440-1681.1994.tb02503.x
CAS PubMed Web of Science® Google Scholar
11Penninga L, Moller CH, Gustafsson F, Steinbruchel DA, Gluud C. Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials. Eur J Clin Pharmacol 2010; 66: 1177–1187.
10.1007/s00228-010-0902-6
CAS PubMed Web of Science® Google Scholar
12Alp NJ, Channon KM. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol 2004; 24: 413–420.
10.1161/01.ATV.0000110785.96039.f6
CAS PubMed Web of Science® Google Scholar
13Hatakeyama K, Harada T, Kagamiyama H. IMP dehydrogenase inhibitors reduce intracellular tetrahydrobiopterin levels through reduction of intracellular GTP levels. Indications of the regulation of GTP cyclohydrolase I activity by restriction of GTP availability in the cells. J Biol Chem 1992; 29: 20734–20739.
Google Scholar
14Ravalli S, Albala A, Ming M, et al. Inducible nitric oxide synthase expression in smooth muscle cells and macrophages of human transplant coronary artery disease. Circulation 1998; 97: 2338–2345.
10.1161/01.CIR.97.23.2338
CAS PubMed Web of Science® Google Scholar
15Sarkar R, Webb RC. Does nitric oxide regulate smooth muscle cell proliferation? A critical appraisal. J Vasc Res 1998; 35: 135–142.
10.1159/000025576
CAS PubMed Web of Science® Google Scholar
16Christopherson KS, Bredt DS. Nitric oxide in excitable tissues: Physiological roles and disease. J Clin Invest 1997; 100: 2424–2429.
10.1172/JCI119783
CAS PubMed Web of Science® Google Scholar
17Cosentino F, Hishikawa K, Katusic ZS, Luscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997; 96: 25–28.
10.1161/01.CIR.96.1.25
CAS PubMed Web of Science® Google Scholar

Citing Literature

All articles

Expression of NO Synthase Under Medication with Cyclosporine A, Mycophenolate Mofetil, and Tacrolimus during Development of Transplant Vasculopathy on Rat Cardiac Allograft

Abstract

Objective

Aims

Results

Conclusions

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Expression of NO Synthase Under Medication with Cyclosporine A, Mycophenolate Mofetil, and Tacrolimus during Development of Transplant Vasculopathy on Rat Cardiac Allograft

Abstract

Objective

Aims

Results

Conclusions

References

Citing Literature

References

Related

Information